Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
414 studies found for:    Open Studies | "Retinal Diseases"
Show Display Options
Rank Status Study
1 Recruiting Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients With Retinal Disease Due to MERTK Mutations
Condition: Retinal Disease
Intervention: Genetic: Recombinant Adeno-Associated Virus
2 Recruiting Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.
Condition: Radiation Retinopathy
Interventions: Drug: 0.5 mg ranibizumab;   Procedure: Targeted Retinal Photocoagulation
3 Not yet recruiting A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention:
4 Not yet recruiting Diabetic Retinopathy Screening in Private Practice
Condition: Diabetic Retinopathy
Interventions: Other: Free screening group;   Other: Pay screening group ($150);   Other: Pay screening group ($300)
5 Not yet recruiting Aflibercept for Retinopathy in the Real World
Condition: Diabetic Retinopathy
Intervention: Other: National Eye Institute Visual Functioning Questionnaire
6 Recruiting Characteristic Analysis of Retinopathy Associated With High Doses of Interferon α-2b Therapy
Condition: Retinopathy
Intervention: Other: Observe the fundus characteristics after therapy.
7 Recruiting Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens
Condition: Diabetic Retinopathy
Interventions: Drug: Metformin;   Drug: Lantus;   Drug: Novomix30
8 Not yet recruiting Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Aflibercept
9 Recruiting Analysis of Angiogenic Factor Levels in Eyes With Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention:
10 Recruiting Non-invasive Measurement of Retinal Blood Flow Based on Vessel Analysis and Fourier Domain Optical Coherence Tomography in Patients With Hypertensive Retinopathy
Condition: Hypertensive Retinopathy
Interventions: Device: Dynamic Vessel Analyzer;   Other: FDOCT;   Other: Ocular perfusion pressure
11 Recruiting Genetic Markers and Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Genetic: genetic analysis
12 Recruiting Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia
Condition: Diabetic Retinopathy
Intervention: Other: Initiation of treatment of diabetes
13 Recruiting Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Aflibercept
14 Recruiting Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery
Condition: Diabetic Retinopathy
Interventions: Drug: Aflibercept;   Drug: Sham
15 Recruiting 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide
16 Recruiting Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: emixustat hydrochloride;   Other: Placebo
17 Recruiting Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: ranibizumab;   Drug: sham;   Procedure: pars plana vitrectomy
18 Recruiting Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
Condition: Nonproliferative Diabetic Retinopathy
Interventions: Drug: Intravitreal aflibercept injection [IAI];   Drug: Sham
19 Recruiting Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy
Condition: Non-proliferative Diabetic Retinopathy
Interventions: Drug: Compound danshen dripping pills;   Drug: Placebo
20 Recruiting RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: Ranibizumab;   Procedure: Laser therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.